Germany • Industry focus
3

Healthcare and life sciences

logo

Osborne Clarke

Mehr Information
Osborne Clarke is experienced in pharmaceutical contracts, cooperation agreements in the pharmaceutical sector, medical device law issues as well as regulatory aspects of cross-border transactions. Among the client roster are pharmaceutical and biotechnology companies, which also benefit from the cooperation with the IP experts, who routinely act across the life sciences sector, this area was strengthened with the arrival of Florian Reiling from Clifford Chance in April 2024; another key contact here is practice head Tim Reinhard. Reinhard is additionally well versed in technology transfer and licensing agreements as well as mediation.
Legal 500 redaktioneller Kommentar
Profil
osborneclarke.com
Soziale Medien

Referenzen

Unabhängig vom Legal 500-Forschungsteam zusammengestellt.

  • 'Many law firms these days advertise their tech expertise, but Osborne Clarke actually has it. The teams have an impressive insight into the tech world and can provide very good advice on the relevant legal issues. An in-house open source team with special technical expertise provides perfect advice on contract constellations in this area.'

  • 'Florian Reiling combines everything that makes a good legal advisor: impressive legal expertise, practical understanding, a pragmatic approach, transparency in dealing with people and, in addition, a winning personality.'

  • 'Andrea Schmoll – available, cooperative and understands our business.'

  • 'Very competent and quick-responding team.'

  • 'Andrea Schmoll: very competent and business-oriented advice. Florian Reiling: very good communication. Lars Kutzner: very competent advice.'

Kernmandanten

  • Haema AG
  • BioNTech SE
  • LTS Lohmann Therapie-Systeme AG
  • Neuraxpharm Arzneimittel GmbH
  • STADA Arzneimittel GmbH
  • Grifols Deutschland GmbH
  • Plasmavita Healthcare GmbH
  • NaturalX Health Ventures GmbH
  • Fresenius Digital Technology GmbH
  • Smart Reporting GmbH

Highlight-Mandate

  • Advising BioNTech SE on the conclusion of three exclusive license and cooperation agreements with Duality Biologics (Suzhou) Co. Ltd.
  • Advising BioNTech SE in connection with master service agreements, supply agreements and clinical trial agreements.
  • Representation of Neuraxpharm Arzneimittel GmbH in social court proceedings before the Berlin Brandenburg State Social Court regarding the formation of drug groups.

Anwält*innen

Praxisleitung

Tim Reinhard 

Weitere Kernanwält*innen

Andrea Schmoll ; Flemming Moos  ; Fabian Christoph; Florian Reiling